Year |
Citation |
Score |
2023 |
Pinto LM, Pailas A, Bondarchenko M, Sharma AB, Neumann K, Rizzo AJ, Jeanty C, Nicot N, Racca C, Graham MK, Naughton C, Liu Y, Chen CL, Meakin PJ, Gilbert N, et al. DAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaks. Nucleic Acids Research. PMID 38038252 DOI: 10.1093/nar/gkad1141 |
0.508 |
|
2023 |
Mori JO, Elhussin I, Brennen WN, Graham MK, Lotan TL, Yates CC, De Marzo AM, Denmeade SR, Yegnasubramanian S, Nelson WG, Denis GV, Platz EA, Meeker AK, Heaphy CM. Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer. Nature Reviews. Urology. PMID 37907729 DOI: 10.1038/s41585-023-00827-x |
0.755 |
|
2023 |
Graham MK, Wang R, Chikarmane R, Wodu B, Vaghasia A, Gupta A, Zheng Q, Hicks J, Sysa-Shah P, Pan X, Castagna N, Liu J, Meyers J, Skaist A, Zhang Y, et al. Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer. Biorxiv : the Preprint Server For Biology. PMID 37905029 DOI: 10.1101/2023.09.07.553268 |
0.762 |
|
2022 |
Graham MK, Chikarmane R, Wang R, Vaghasia A, Gupta A, Zheng Q, Wodu B, Pan X, Castagna N, Liu J, Meyers J, Skaist A, Wheelan S, Simons BW, Bieberich C, et al. Single-cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate. The Prostate. PMID 36373171 DOI: 10.1002/pros.24460 |
0.698 |
|
2020 |
Esopi D, Graham MK, Brosnan-Cashman JA, Meyers J, Vaghasia A, Gupta A, Kumar B, Haffner MC, Heaphy CM, De Marzo AM, Meeker AK, Nelson WG, Wheelan SJ, Yegnasubramanian S. Pervasive promoter hypermethylation of silenced TERT alleles in human cancers. Cellular Oncology (Dordrecht). PMID 32468444 DOI: 10.1007/S13402-020-00531-7 |
0.701 |
|
2020 |
Heaphy CM, Haffner MC, Graham MK, Lim D, Davis C, Corey E, Epstein JI, Eisenberger MA, Wang H, De Marzo AM, Meeker AK, Lotan TL. Telomere lengths differ significantly between small cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate. Human Pathology. PMID 32389660 DOI: 10.1016/J.Humpath.2020.04.014 |
0.658 |
|
2019 |
Graham MK, Kim J, Da J, Brosnan-Cashman JA, Rizzo A, Baena Del Valle JA, Chia L, Rubenstein M, Davis C, Zheng Q, Cope L, Considine M, Haffner MC, De Marzo AM, Meeker AK, et al. Functional loss of ATRX and TERC activates Alternative Lengthening of Telomeres (ALT) in LAPC4 prostate cancer cells. Molecular Cancer Research : McR. PMID 31611308 DOI: 10.1158/1541-7786.Mcr-19-0654 |
0.738 |
|
2019 |
Cejas P, Drier Y, Dreijerink KMA, Brosens LAA, Deshpande V, Epstein CB, Conemans EB, Morsink FHM, Graham MK, Valk GD, Vriens MR, Castillo CF, Ferrone CR, Adar T, Bowden M, et al. Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors. Nature Medicine. PMID 31263286 DOI: 10.1038/S41591-019-0493-4 |
0.321 |
|
2018 |
Brosnan-Cashman JA, Yuan M, Graham MK, Rizzo AJ, Myers KM, Davis C, Zhang R, Esopi DM, Raabe EH, Eberhart CG, Heaphy CM, Meeker AK. ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner. Plos One. 13: e0204159. PMID 30226859 DOI: 10.1371/Journal.Pone.0204159 |
0.661 |
|
2018 |
Brosnan-Cashman JA, Graham MK, Rizzo AJ, Myers K, Zhang R, Göger E, Zarinshenas R, Davis C, Yuan M, Rakheja D, Raabe EH, Eberhart CG, Heaphy CM, Meeker AK. Abstract B14: Establishment and characterization of in vitro models of alternative lengthening of telomeres (ALT) in pediatric high-grade glioma Cancer Research. 78. DOI: 10.1158/1538-7445.Pedca17-B14 |
0.66 |
|
2017 |
Baena-Del Valle JA, Zheng Q, Esopi DM, Rubenstein M, Hubbard GK, Moncaliano MC, Hruszkewycz A, Vaghasia A, Yegnasubramanian S, Wheelan SJ, Meeker AK, Heaphy CM, Graham MK, De Marzo AM. MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer. The Journal of Pathology. PMID 28888037 DOI: 10.1002/Path.4980 |
0.752 |
|
2017 |
Graham MK, Meeker A. Telomeres and telomerase in prostate cancer development and therapy. Nature Reviews. Urology. PMID 28675175 DOI: 10.1038/Nrurol.2017.104 |
0.727 |
|
2017 |
Becker AP, Bell EH, Fleming J, McElroy JP, Fabian D, Beyer S, Salavaggione AL, Graham MK, Heaphy CM, Oehlke O, Staszewski O, Prinz M, Grosu A, Chakravarti A. Comprehensive assessment of ATRX mutation, protein expression, and alternative lengthening of telomeres (ALT) phenotype in grade II and III gliomas. Journal of Clinical Oncology. 35: 2064-2064. DOI: 10.1200/Jco.2017.35.15_Suppl.2064 |
0.303 |
|
2017 |
Rizzo AJ, Brosnan-Cashman JA, Graham MK, Meeker AK, Heaphy CM. Abstract 3464: CRISPR-mediated inactivation of ATRX and DAXX in pancreatic neuroendocrine tumor cell lines Cancer Research. 77: 3464-3464. DOI: 10.1158/1538-7445.Am2017-3464 |
0.666 |
|
2017 |
Graham MK. Abstract 3412: Functional knockout ofATRXorDAXXpermits the alternative lengthening of telomeres (ALT) mechanism in prostate cancer cells Cancer Research. 77: 3412-3412. DOI: 10.1158/1538-7445.Am2017-3412 |
0.66 |
|
2016 |
Graham MK, Principessa L, Antony L, Meeker AK, Isaacs JT. Low p16(INK4a) Expression in Early Passage Human Prostate Basal Epithelial Cells Enables Immortalization by Telomerase Expression Alone. The Prostate. PMID 27859428 DOI: 10.1002/Pros.23276 |
0.609 |
|
2016 |
Graham MK, Brosnan-Cashman J, Rizzo A, Haffner M, Meeker A, Heaphy C. Abstract 4767: Generating and characterizing novel prostate cancer cell lines that employ the alternative lengthening of telomeres (ALT) telomere maintenance mechanism Cancer Research. 76: 4767-4767. DOI: 10.1158/1538-7445.Am2016-4767 |
0.744 |
|
2015 |
Graham MK, Brown TR, Miller PS. Targeting the human androgen receptor gene with platinated triplex-forming oligonucleotides. Biochemistry. 54: 2270-82. PMID 25768916 DOI: 10.1021/Bi501565N |
0.558 |
|
2012 |
Graham MK, Miller PS. Inhibition of transcription by platinated triplex-forming oligonucleotides. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 17: 1197-208. PMID 22965663 DOI: 10.1007/S00775-012-0933-9 |
0.462 |
|
2012 |
Graham MK, Brown TR, Miller PS. Abstract C19: Targeting the human androgen receptor gene with platinum-conjugated triplex-forming oligonucleotides Cancer Research. 72: C19-C19. DOI: 10.1158/1538-7445.Prca2012-C19 |
0.611 |
|
Show low-probability matches. |